-
1
-
-
0024519006
-
Acute promyelocytic leukemia: Treatment results during a decade at Memorial Hospital
-
Cunningham I, Gee TS, Reich LM, Kempin SJ, Naval AN and Clarkson BD: Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood 73: 1116-1122, 1989. (Pubitemid 19107411)
-
(1989)
Blood
, vol.73
, Issue.5
, pp. 1116-1122
-
-
Cunningham, I.1
Gee, T.S.2
Reich, L.M.3
Kempin, S.J.4
Naval, A.N.5
Clarkson, B.D.6
-
2
-
-
39049174712
-
Management of APL in developing countries: Epidemiology, challenges and opportunities for international collaboration
-
Ribeiro RC and Rego E: Management of APL in developing countries: epidemiology, challenges and opportunities for international collaboration. Hematology Am Soc Hematol Educ Program pp162-168, 2006.
-
(2006)
Hematology Am Soc Hematol Educ Program
, pp. 162-168
-
-
Ribeiro, R.C.1
Rego, E.2
-
3
-
-
0023865201
-
Acute promyelocytic leukemia: Therapy results and prognostic factors
-
Sanz MA, Jarque I, Martin G, et al: Acute promyelocytic leukemia. Therapy results and prognostic factors. Cancer 61: 7-13, 1988. (Pubitemid 18023103)
-
(1988)
Cancer
, vol.61
, Issue.1
, pp. 7-13
-
-
Sanz, M.A.1
Jarque, I.2
Martin, G.3
Lorenzo, I.4
Martinez, J.5
Rafecas, J.6
Pastor, E.7
Sayas, M.J.8
Sanz, G.9
Gomis, F.10
-
4
-
-
41949111045
-
Acute promyelocytic leukemia: From highly fatal to highly curable
-
Wang ZY and Chen Z: Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111: 2505-2515, 2008.
-
(2008)
Blood
, vol.111
, pp. 2505-2515
-
-
Wang, Z.Y.1
Chen, Z.2
-
5
-
-
0033570955
-
Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients
-
Niu C, Yan H, Yu T, et al: Studies on treatment of acute promye-locytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood 94: 3315-3324, 1999. (Pubitemid 29536124)
-
(1999)
Blood
, vol.94
, Issue.10
, pp. 3315-3324
-
-
Niu, C.1
Yan, H.2
Yu, T.3
Sun, S.4
Liu, J.-X.5
Xiu-Song, L.6
Wu, W.7
Zhang, F.-Q.8
Chen, Y.9
Zhou, L.10
Li, J.-M.11
Zeng, X.-Y.12
Yang, R.-R.O.13
Yuan, M.-M.14
Ren, M.-Y.15
Gu, F.-Y.16
Cao, Q.17
Gu, B.-W.18
Su, X.-Y.19
Chen, G.-Q.20
Xiong, S.-M.21
Zhang, T.-D.22
Waxman, S.23
Wang, Z.-Y.24
Chen, Z.25
Hu, J.26
Shen, Z.-X.27
Chen, S.-J.28
more..
-
6
-
-
62549083523
-
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
-
Hu J, Liu YF, Wu CF, et al: Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci USA 106: 3342-3347, 2009.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 3342-3347
-
-
Hu, J.1
Liu, Y.F.2
Wu, C.F.3
-
7
-
-
47949084737
-
Mineral arsenicals in traditional medicines: Orpiment, realgar, and arsenolite
-
Liu J, Lu Y, Wu Q, Goyer RA and Waalkes MP: Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite. J Pharmacol Exp Ther 326: 363-368, 2008.
-
(2008)
J Pharmacol Exp Ther
, vol.326
, pp. 363-368
-
-
Liu, J.1
Lu, Y.2
Wu, Q.3
Goyer, R.A.4
Waalkes, M.P.5
-
8
-
-
0036566529
-
Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: A pilot report
-
DOI 10.1182/blood.V99.9.3136
-
Lu DP, Qiu JY, Jiang B, et al: Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. Blood 99: 3136-3143, 2002. (Pubitemid 34525290)
-
(2002)
Blood
, vol.99
, Issue.9
, pp. 3136-3143
-
-
Lu, D.-P.1
Qiu, J.-Y.2
Jiang, B.3
Wang, Q.4
Liu, K.-Y.5
Liu, Y.-R.6
Chen, S.-S.7
-
9
-
-
78650740077
-
As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia
-
Mao JH, Sun XY, Liu JX, et al: As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia. Proc Natl Acad Sci USA 107: 21683-21688, 2010.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 21683-21688
-
-
Mao, J.H.1
Sun, X.Y.2
Liu, J.X.3
-
10
-
-
79952706390
-
Realgar and realgar-containing Liu-Shen-Wan are less acutely toxic than arsenite and arsenate
-
Liu J, Liang SX, Lu YF, Miao JW, Wu Q and Shi JS: Realgar and realgar-containing Liu-Shen-Wan are less acutely toxic than arsenite and arsenate. J Ethnopharmacol 134: 26-31, 2011.
-
(2011)
J Ethnopharmacol
, vol.134
, pp. 26-31
-
-
Liu, J.1
Liang, S.X.2
Lu, Y.F.3
Miao, J.W.4
Wu, Q.5
Shi, J.S.6
-
11
-
-
0030610686
-
3 exerts dose-dependent dual effects on APL cells
-
Chen GQ, Shi XG, Tang W, et al: Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood 89: 3345-3353, 1997. (Pubitemid 27229821)
-
(1997)
Blood
, vol.89
, Issue.9
, pp. 3345-3353
-
-
Chen, G.-Q.1
Shi, X.-G.2
Tang, W.3
Xiong, S.-M.4
Zhu, J.5
Cai, X.6
Man, Z.-G.7
Ni, J.-H.8
Shi, G.-Y.9
Jia, P.-M.10
Liu, M.-M.11
He, K.-L.12
Niu, C.13
Ma, J.14
Zhang, P.15
Zhang, T.-D.16
Paul, P.17
Naoe, T.18
Kitamura, K.19
Miller, W.20
Waxman, S.21
Wang, Z.-Y.22
De The, H.23
Chen, S.-J.24
Chen, Z.25
more..
-
12
-
-
33846992732
-
Arsenic trioxide and acute promyelocytic leukemia: Clinical and biological
-
Acute Promyelocytic Leukemia: Molecular Genetics, Mouse Models and Targeted Therapy
-
Chen Z, Zhao WL, Shen ZX, et al: Arsenic trioxide and acute promyelocytic leukemia: clinical and biological. Curr Top Microbiol Immunol 313: 129-144, 2007. (Pubitemid 47400336)
-
(2007)
Current Topics in Microbiology and Immunology
, vol.313
, pp. 129-144
-
-
Chen, Z.1
Zhao, W.-L.2
Shen, Z.-X.3
Li, J.-M.4
Chen, S.-J.5
Zhu, J.6
Lallemand-Breittenbach, V.7
Zhou, J.8
Guillemin, M.-C.9
Vitoux, D.10
De The, H.11
-
13
-
-
0010740572
-
4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML- RARalpha/PML proteins
-
Chen GQ, Zhu J, Shi XG, et al: In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 88: 1052-1061, 1996. (Pubitemid 26333331)
-
(1996)
Blood
, vol.88
, Issue.3
, pp. 1052-1061
-
-
Chen, G.-Q.1
Zhu, J.2
Shi, X.-G.3
Ni, J.-H.4
Zhong, H.-J.5
Si, G.-Y.6
Jin, X.-L.7
Tang, W.8
Li, X.-S.9
Xong, S.-M.10
Shen, Z.-X.11
Sun, G.-L.12
Ma, J.13
Zhang, P.14
Zhang, T.-D.15
Gazin, C.16
Naoe, T.17
Chen, S.-J.18
Wang, Z.-Y.19
Chen, Z.20
more..
-
14
-
-
0033974883
-
Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia
-
Cai X, Shen YL, Zhu Q, et al: Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 14: 262-270, 2000. (Pubitemid 30095381)
-
(2000)
Leukemia
, vol.14
, Issue.2
, pp. 262-270
-
-
Cai, X.1
Shen, Y.-L.2
Zhu, Q.3
Jia, P.-M.4
Yu, Y.5
Zhou, L.6
Huang, Y.7
Zhang, J.-W.8
Xiong, S.-M.9
Chen, S.-J.10
Wang, Z.-Y.11
Chen, Z.12
Chen, G.-Q.13
-
15
-
-
0029784514
-
The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases
-
Brill S, Li S, Lyman CW, et al: The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases. Mol Cell Biol 16: 4869-4878, 1996. (Pubitemid 26272142)
-
(1996)
Molecular and Cellular Biology
, vol.16
, Issue.9
, pp. 4869-4878
-
-
Brill, S.1
Li, S.2
Lyman, C.W.3
Church, D.M.4
Wasmuth, J.J.5
Weissbach, L.6
Bernards, A.7
Snijders, A.J.8
-
17
-
-
0027328191
-
Activin receptor-like kinases: A novel subclass of cell-surface receptors with predicted serine/threonine kinase activity
-
Ten Dijke P, Ichijo H, Franzen P, et al: Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8: 2879-2887, 1993. (Pubitemid 23279121)
-
(1993)
Oncogene
, vol.8
, Issue.10
, pp. 2879-2887
-
-
Ten, D.P.1
Ichijo, H.2
Franzen, P.3
Schulz, P.4
Saras, J.5
Toyoshima, H.6
Heldin, C.-H.7
Miyazono, K.8
-
18
-
-
77957020273
-
Comparative proteome study of apoptosis induced by As4S4 in retinoid acid resistant human acute promyelocytic leukemia NB4-R1 cells
-
Qi J, He P, Chen W, Wang H, Wang X and Zhang M: Comparative proteome study of apoptosis induced by As4S4 in retinoid acid resistant human acute promyelocytic leukemia NB4-R1 cells. Leuk Res 34: 1506-1516, 2010.
-
(2010)
Leuk Res
, vol.34
, pp. 1506-1516
-
-
Qi, J.1
He, P.2
Chen, W.3
Wang, H.4
Wang, X.5
Zhang, M.6
-
19
-
-
33747809671
-
Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding
-
Wu JZ and Ho PC: Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding. Eur J Pharm Sci 29: 35-44, 2006.
-
(2006)
Eur J Pharm Sci
, vol.29
, pp. 35-44
-
-
Wu, J.Z.1
Ho, P.C.2
-
20
-
-
39849084926
-
Roles of PI3-K/Akt pathways in nanoparticle realgar powders-induced apoptosis in U937 cells
-
DOI 10.1111/j.1745-7254.2008.00759.x
-
Xi RG, Huang J, Li D, Wang XB and Wu LJ: Roles of PI3-K/Akt pathways in nanoparticle realgar powders-induced apoptosis in U937 cells. Acta Pharmacol Sin 29: 355-363, 2008. (Pubitemid 351316991)
-
(2008)
Acta Pharmacologica Sinica
, vol.29
, Issue.3
, pp. 355-363
-
-
Xi, R.-G.1
Huang, J.2
Li, D.3
Wang, X.-B.4
Wu, L.-J.5
|